Similar articles for PMID: 27069184

Year	Number of Results
2004	3
2005	2
2006	2
2007	3
2008	2
2009	2
2010	3
2011	8
2012	17
2013	15
2014	7
2015	18
2016	17
2017	14
2018	18
2019	3
2020	14
2021	14
2022	9
2023	4
2024	0

1

Early-stage Node-negative (T1-T2N0) Anal Cancer Treated with Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy.

Franco P, Arcadipane F, Ragona R, Mistrangelo M, Cassoni P, Rondi N, Morino M, Racca P, Ricardi U. Franco P, et al. Anticancer Res. 2016 Apr;36(4):1943-8. Anticancer Res. 2016. PMID: 27069184 Free article.

2

Locally Advanced (T3-T4 or N+) Anal Cancer Treated with Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy.

Franco P, Arcadipane F, Ragona R, Mistrangelo M, Cassoni P, Rondi N, Morino M, Racca P, Ricardi U. Franco P, et al. Anticancer Res. 2016 Apr;36(4):2027-32. Anticancer Res. 2016. PMID: 27069197 Free article. Clinical Trial.

3

Intensity-modulated radiation therapy with simultaneous integrated boost combined with concurrent chemotherapy for the treatment of anal cancer patients: 4-year results of a consecutive case series.

Franco P, Mistrangelo M, Arcadipane F, Munoz F, Sciacero P, Spadi R, Migliaccio F, Angelini V, Bombaci S, Rondi N, Numico G, Ragona R, Cassoni P, Morino M, Racca P, Ricardi U. Franco P, et al. Cancer Invest. 2015 Jul;33(6):259-66. doi: 10.3109/07357907.2015.1028586. Epub 2015 May 7. Cancer Invest. 2015. PMID: 25950188 Free article. Clinical Trial.

4

Volumetric modulated arc therapy (VMAT) in the combined modality treatment of anal cancer patients.

Franco P, Arcadipane F, Ragona R, Mistrangelo M, Cassoni P, Munoz F, Rondi N, Morino M, Racca P, Ricardi U. Franco P, et al. Br J Radiol. 2016;89(1060):20150832. doi: 10.1259/bjr.20150832. Epub 2016 Feb 3. Br J Radiol. 2016. PMID: 26838953 Free PMC article.

5

Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer.

Han K, Cummings BJ, Lindsay P, Skliarenko J, Craig T, Le LW, Brierley J, Wong R, Dinniwell R, Bayley AJ, Dawson LA, Ringash J, Krzyzanowska MK, Moore MJ, Chen EX, Easson AM, Kassam Z, Cho C, Kim J. Han K, et al. Int J Radiat Oncol Biol Phys. 2014 Nov 1;90(3):587-94. doi: 10.1016/j.ijrobp.2014.06.061. Epub 2014 Sep 3. Int J Radiat Oncol Biol Phys. 2014. PMID: 25194664

6

Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy.

Kachnic LA, Tsai HK, Coen JJ, Blaszkowsky LS, Hartshorn K, Kwak EL, Willins JD, Ryan DP, Hong TS. Kachnic LA, et al. Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):153-8. doi: 10.1016/j.ijrobp.2010.09.030. Epub 2010 Nov 20. Int J Radiat Oncol Biol Phys. 2012. PMID: 21095071

7

Image-guided IMRT with simultaneous integrated boost as per RTOG 0529 for the treatment of anal cancer.

Arcadipane F, Franco P, Ceccarelli M, Furfaro G, Rondi N, Trino E, Martini S, Iorio GC, Mistrangelo M, Cassoni P, Racca P, Morino M, Ricardi U. Arcadipane F, et al. Asia Pac J Clin Oncol. 2018 Jun;14(3):217-223. doi: 10.1111/ajco.12768. Epub 2017 Aug 30. Asia Pac J Clin Oncol. 2018. PMID: 28856848

8

Implementing Intensity-modulated Radiotherapy with Simultaneous Integrated Boost for Anal Cancer: 3 Year Outcomes at Two Sydney Institutions.

Yates A, Carroll S, Kneebone A, Tse R, Horvath L, Byrne C, Solomon M, Hruby G. Yates A, et al. Clin Oncol (R Coll Radiol). 2015 Dec;27(12):700-7. doi: 10.1016/j.clon.2015.08.006. Epub 2015 Sep 14. Clin Oncol (R Coll Radiol). 2015. PMID: 26382849

9

Dosimetric predictors of acute hematologic toxicity during concurrent intensity-modulated radiotherapy and chemotherapy for anal cancer.

Franco P, Ragona R, Arcadipane F, Mistrangelo M, Cassoni P, Rondi N, Morino M, Racca P, Ricardi U. Franco P, et al. Clin Transl Oncol. 2017 Jan;19(1):67-75. doi: 10.1007/s12094-016-1504-2. Epub 2016 Apr 1. Clin Transl Oncol. 2017. PMID: 27037814

10

Clinical outcome in patients treated with simultaneous integrated boost - intensity modulated radiation therapy (SIB-IMRT) with and without concurrent chemotherapy for squamous cell carcinoma of the anal canal.

Tomasoa NB, Meulendijks D, Nijkamp J, Cats A, Dewit L. Tomasoa NB, et al. Acta Oncol. 2016 Jun;55(6):760-6. doi: 10.3109/0284186X.2015.1124141. Epub 2016 Feb 15. Acta Oncol. 2016. PMID: 26878244 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

147 results

Results by year